We use cookies on this site to enhance your user experience.
Osicent 80 mg, also known by its generic name Osimertinib, is a medication used in the treatment of non-small cell lung cancer (NSCLC), particularly in patients with certain mutations in the epidermal growth factor receptor (EGFR) gene.